Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventral Tegmental Area | 13 | 2023 | 26 | 2.430 |
Why?
|
| Nicotine | 12 | 2023 | 38 | 2.300 |
Why?
|
| Dopaminergic Neurons | 10 | 2023 | 22 | 2.010 |
Why?
|
| Neurons | 6 | 2025 | 131 | 1.390 |
Why?
|
| Serotonin | 2 | 2025 | 4 | 1.180 |
Why?
|
| Optogenetics | 2 | 2023 | 5 | 0.990 |
Why?
|
| Cocaine | 1 | 2023 | 5 | 0.880 |
Why?
|
| Animals | 19 | 2025 | 1817 | 0.880 |
Why?
|
| Dopamine | 6 | 2023 | 26 | 0.850 |
Why?
|
| Nervous System | 1 | 2023 | 5 | 0.850 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2023 | 22 | 0.840 |
Why?
|
| Tobacco Use Disorder | 1 | 2023 | 49 | 0.790 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2022 | 2 | 0.780 |
Why?
|
| GABAergic Neurons | 1 | 2022 | 2 | 0.780 |
Why?
|
| Nucleus Accumbens | 3 | 2023 | 7 | 0.630 |
Why?
|
| Nicotinic Agonists | 4 | 2020 | 14 | 0.470 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 26 | 0.450 |
Why?
|
| Mice | 6 | 2024 | 719 | 0.450 |
Why?
|
| Rats | 9 | 2023 | 251 | 0.450 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2023 | 131 | 0.360 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 41 | 0.350 |
Why?
|
| Ethanol | 2 | 2021 | 45 | 0.340 |
Why?
|
| Glioblastoma | 2 | 2020 | 7 | 0.330 |
Why?
|
| Spheroids, Cellular | 3 | 2020 | 11 | 0.330 |
Why?
|
| Pregnancy | 8 | 2023 | 103 | 0.310 |
Why?
|
| RNA, Messenger | 5 | 2021 | 69 | 0.300 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2018 | 10 | 0.290 |
Why?
|
| Humans | 8 | 2025 | 5485 | 0.290 |
Why?
|
| MicroRNAs | 4 | 2021 | 55 | 0.270 |
Why?
|
| Prefrontal Cortex | 3 | 2011 | 39 | 0.270 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 72 | 0.260 |
Why?
|
| Neurotransmitter Agents | 1 | 2025 | 2 | 0.240 |
Why?
|
| Central Nervous System | 1 | 2025 | 8 | 0.240 |
Why?
|
| Male | 8 | 2022 | 2770 | 0.230 |
Why?
|
| Acute Pain | 1 | 2024 | 4 | 0.230 |
Why?
|
| Maternal Exposure | 2 | 2021 | 5 | 0.220 |
Why?
|
| Signal Transduction | 3 | 2020 | 225 | 0.220 |
Why?
|
| Morphine | 1 | 2023 | 2 | 0.220 |
Why?
|
| Nitriles | 2 | 2020 | 11 | 0.220 |
Why?
|
| Sulfones | 2 | 2020 | 10 | 0.220 |
Why?
|
| Nociceptive Pain | 1 | 2023 | 2 | 0.210 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 55 | 0.210 |
Why?
|
| Channelrhodopsins | 1 | 2022 | 2 | 0.200 |
Why?
|
| Bicuculline | 1 | 2022 | 3 | 0.200 |
Why?
|
| Cell Survival | 2 | 2020 | 57 | 0.200 |
Why?
|
| Optical Imaging | 1 | 2022 | 18 | 0.190 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 2 | 0.180 |
Why?
|
| Neuroglia | 1 | 2020 | 9 | 0.180 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 3 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 23 | 0.180 |
Why?
|
| Actin Cytoskeleton | 1 | 2020 | 11 | 0.180 |
Why?
|
| NF-kappa B | 1 | 2020 | 11 | 0.180 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 35 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 55 | 0.170 |
Why?
|
| Female | 8 | 2023 | 2816 | 0.170 |
Why?
|
| Apoptosis | 1 | 2020 | 55 | 0.170 |
Why?
|
| Gene Expression | 1 | 2020 | 52 | 0.160 |
Why?
|
| Hippocampus | 2 | 2010 | 73 | 0.160 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2018 | 8 | 0.160 |
Why?
|
| Mesencephalon | 1 | 2016 | 9 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 12 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 26 | 0.130 |
Why?
|
| Action Potentials | 2 | 2016 | 28 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 175 | 0.110 |
Why?
|
| Carbachol | 2 | 2010 | 8 | 0.110 |
Why?
|
| Markov Chains | 2 | 2010 | 18 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 2011 | 3 | 0.100 |
Why?
|
| Transcriptome | 2 | 2023 | 47 | 0.090 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 11 | 0.090 |
Why?
|
| Oscillometry | 1 | 2010 | 6 | 0.090 |
Why?
|
| Ganglionic Stimulants | 2 | 2019 | 5 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 350 | 0.060 |
Why?
|
| Gyrus Cinguli | 1 | 2024 | 5 | 0.060 |
Why?
|
| Somatosensory Cortex | 1 | 2024 | 14 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2024 | 21 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 53 | 0.050 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2023 | 2 | 0.050 |
Why?
|
| Microdialysis | 1 | 2023 | 4 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2023 | 4 | 0.050 |
Why?
|
| Calcium | 1 | 2023 | 30 | 0.050 |
Why?
|
| Electrophysiology | 2 | 2014 | 23 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 8 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 7 | 0.040 |
Why?
|
| Vimentin | 1 | 2020 | 5 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2020 | 11 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2020 | 7 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 16 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2020 | 8 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 28 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 21 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 131 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 8 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 14 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 10 | 0.040 |
Why?
|
| Smoking | 1 | 2018 | 94 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2016 | 4 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 16 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 12 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 25 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 32 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 20 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 30 | 0.030 |
Why?
|
| Software | 1 | 2016 | 59 | 0.030 |
Why?
|
| Entropy | 1 | 2014 | 12 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2011 | 6 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 10 | 0.020 |
Why?
|
| Axotomy | 1 | 2011 | 2 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2011 | 41 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2011 | 134 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 50 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 38 | 0.020 |
Why?
|
| Nerve Net | 1 | 2010 | 46 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 275 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 176 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 90 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 242 | 0.020 |
Why?
|